Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-01-29 @ 12:03 AM
Study NCT ID:
NCT04222920
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2020-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adalimumab Dose Reduction Aiming Low Serum Concentration With Control of Disease Activity
Sponsor:
Reade Rheumatology Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
ADDORA-low
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None